Risk factors for functional decline among survivors of Gram-negative bloodstream infection: A prospective cohort study
Adi Turjeman(Rabin Medical Center), Leonard Leibovici(Tel Aviv University), Elad Goldberg, Nesrin Ghanem‐Zoubi(Rambam Health Care Campus), Dafna Yahav(Sheba Medical Center), Antonella Santoro, Erica Franceschini(University of Modena and Reggio Emilia), Hiba Zayyad(Bar-Ilan University), Marianna Meschiari(Azienda Ospedaliero-Universitaria di Modena), Noa Eliakim‐Raz(Tel Aviv University), Yaakov Dickstein(Tel Aviv Sourasky Medical Center), Tanya Babich(Unknown), Ami Neuberger(Technion – Israel Institute of Technology), Mical Paul(Technion – Israel Institute of Technology), Claudia Venturelli(Azienda Ospedaliero-Universitaria di Modena), Anat Stern(Technion – Israel Institute of Technology), Elias Maroun(Rambam Health Care Campus), Cristina Mussini(University of Modena and Reggio Emilia), Fidi Koppel(Rambam Health Care Campus), Jihad Bishara(Tel Aviv University), Barak Pertzov(Tel Aviv University), Roni Bitterman(Rambam Health Care Campus), Giovanni Dolci
DOAJ (DOAJ: Directory of Open Access Journals)
January 1, 2021
Cited by 0
Related Papers
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)
|Clinical Microbiology and Infection|2021|1k
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|998
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
|Nature Communications|2020|846
Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Antibiotic Therapy for Sepsis
|Antimicrobial Agents and Chemotherapy|2010|727